Effect of Incentive Spirometery on Asthmatic Pregnant Women

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

Detailed Description
-----------------
This study will provide an evidence basis for obstetricians and physical therapist for women's health about the effect of spirometry on asthma during pregnancy.

Official Title
-----------------
Effect of Incentive Spirometery on Asthmatic Pregnant Women

Conditions
-----------------
Asthmatic, Pregnant With Complication

Intervention / Treatment
-----------------
* Drug: pulmicort inhaler
* Device: Incentive spirometer treatment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The patients will have the following criteria: Their age will range from 30 to40years old. Body mass index (BMI) will range from 25-29.9 kg/m2. All patients will be clinically and medically stable. Exclusion Criteria: Patients will be excluded from the study if they have the following: Diabetes mellitus. Severe hypertension. Neurological and neuromuscular disorders. Blindness. Developed moderate and severe degree of pleural effusion. Cardiovascular instability. Chronic chest disease.

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 40 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: pulmicort inhaler<br>Group (A) consists of 30 patients. They will receive their inhaled glucocorticoids (pulmicort inhaler) on needs. | Drug: pulmicort inhaler<br>* Each woman in both groups (A&B) will receive pulmicort inhaler on needs.<br>|
| Experimental: incentive spirometer<br>Group (B) consists of 30 patients. They will receive the same medical treatment and incentive spirometer program 3 days per week for six weeks. | Drug: pulmicort inhaler<br>* Each woman in both groups (A&B) will receive pulmicort inhaler on needs.<br>Device: Incentive spirometer treatment<br>* Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Assessing the change in lung functions | The spirometer will be used for assessment of lung functions including total lung capacity (TLC) (litre), which is the most widely used functional index in the asthma follow up. | at baseline and after 6 weeks of intervention | 
| Assessing the change in symptoms of asthma | The Asthma Control Test provides a numerical score to help you and your healthcare provider determine if your asthma symptoms are well controlled. Take this test if you are 12 years or older. Share the score with your healthcare provider. | at baseline and after 6 weeks of intervention |